NYSE:TJX
NYSE:TJXSpecialty Retail

TJX (TJX): Revisiting Valuation After Analyst Upgrades, Dividend Growth and Buybacks Boost Confidence

TJX Companies (TJX) is back in the spotlight after a wave of upbeat analyst calls, fresh Buy coverage, and a reaffirmed dividend, all landing as the stock trades around record highs. See our latest analysis for TJX Companies. Those bullish calls are landing on a stock that has already been trending higher. The latest share price is $156.14 and a strong year to date share price return has helped to reinforce a three year total shareholder return above 100 percent, suggesting momentum is still...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

PepsiCo’s Elliott-Backed Overhaul Might Change The Case For Investing In PepsiCo (PEP)

Earlier this month, PepsiCo outlined a multi-year turnaround plan shaped with activist investor Elliott Management, including cutting nearly 20% of its U.S. SKUs, closing manufacturing plants, reviewing its North American supply chain, and guiding to roughly flat 2025 earnings before targeting margin expansion and higher core EPS growth in 2026. At the same time, PepsiCo is shifting toward affordability and innovation, lowering some prices, launching products with simpler ingredients, and...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Is Victoria's Secret Stock Price Rally Justified After Recent Double Digit Gains?

Wondering if Victoria's Secret at around $54 a share is a comeback story worth paying up for, or a brand trading ahead of its true value? This breakdown is designed to help you answer that. After climbing 11.1% over the last week, 54.0% over the past month, and 34.8% year to date, the stock is now up 11.9% over the last year and 42.4% over three years. This naturally raises the question of whether the market is getting ahead of itself. Investors have been reacting to a mix of headline...
BATS:CBOE
BATS:CBOECapital Markets

How Investors Are Reacting To Cboe Global Markets (CBOE) Barclays Upgrade And 24-Hour Russell 2000 Options

Earlier this month, Barclays upgraded Cboe Global Markets to Overweight, citing the company’s healthy growth in index options, rising retail options activity, and its sharpened focus on core derivatives while selling sub-scale businesses in regions such as Australia and Canada. Barclays also highlighted Cboe’s plan to extend Russell 2000 Index options to nearly 24-hour trading from February 2026, underscoring how expanded access to proprietary index products is becoming central to the...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Qifu Technology (QFIN): Reassessing Valuation After Fresh Optimism in China’s Fintech Lending Sector

Qfin Holdings (QFIN) is back on investors radar after fresh research highlighted it as a rare bright spot in China fintech, with its capital light, fee driven model standing out against broad sector pessimism. See our latest analysis for Qfin Holdings. Despite that upbeat narrative, the 30 day share price return of negative 14.8% and year to date share price return of negative 48.8% show sentiment is still fragile. This is true even though the 3 year total shareholder return of 28% and 5 year...
NYSE:C
NYSE:CBanks

Is It Too Late To Consider Citi After A 181% Three Year Surge?

If you are wondering whether Citigroup is still a value play after such a big run, or if you have already missed the boat, you are in the right place to break that down calmly and clearly. The stock has climbed 2.7% over the last week, 8.7% over the last month, and an impressive 59.9% year to date, with a 61.8% gain over the past year and a massive 181.1% rise over three years. This performance has clearly shifted how the market views its risk and reward profile. Recent headlines have...
NYSE:VRT
NYSE:VRTElectrical

Assessing Vertiv’s Valuation After a 1131.2% Three Year Surge in 2025

If you are wondering whether Vertiv Holdings Co is still a buy after its big run, you are not alone. This breakdown is going to focus squarely on what the current share price really implies about future returns. The stock has cooled off recently, down 14.7% over the last week and 7.0% over the past month, but it is still up 36.3% year to date and an eye catching 1131.2% over three years. This naturally raises the question of how much upside might be left versus the risk of a pullback. Behind...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai (BBAI): Assessing Valuation After Strong Multi‑Year Gains and Recent Share Price Pullback

BigBear.ai Holdings (BBAI) has been on a wild ride, with the stock up roughly 55% year to date and more than 150% over the past year, despite lingering net losses. See our latest analysis for BigBear.ai Holdings. The recent pullback, including a 1 month share price return of minus 11.0 percent from a 90 day gain of 26.1 percent and a standout 3 year total shareholder return of 678.1 percent, suggests momentum is cooling, but the longer term narrative remains powerful. If BigBear.ai has you...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS): Assessing Valuation as Rapid Store Expansion and Same‑Store Sales Growth Accelerate

Rapid expansion is the big story for Dutch Bros (BROS) right now, with new drive thru shops planned across Louisiana, Florida, Tennessee, and Ohio, and rising same store sales backing up that growth. See our latest analysis for Dutch Bros. That expansion story is increasingly reflected in the market, with the share price at $61.16, an 8.61% year to date share price return and a powerful 98.44% three year total shareholder return suggesting momentum is still building rather than fading. If...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle (ORCL) Is Down 12.7% After Hiking AI Capex To $50 Billion And Posting Q2 Results - Has The Bull Case Changed?

Earlier this week, Oracle reported fiscal Q2 2026 results showing revenue of US$16.06 billion and net income of US$6.14 billion, alongside a sharp increase in AI‑driven cloud infrastructure backlog and a quarterly dividend declaration of US$0.50 per share. At the same time, Oracle’s decision to lift its fiscal 2026 capital expenditure plan to about US$50 billion, largely to fund AI data centers for customers such as OpenAI, Meta, and Nvidia, has intensified concerns about its growing debt...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Is Apellis Pharmaceuticals Attractive After Recent 26% Surge Despite Mixed Valuation Signals?

Wondering if Apellis Pharmaceuticals is finally offering real value at today’s price, or if it is just another biotech value trap in disguise, you are not alone. The stock has jumped 6.8% over the last week and 26.0% over the past month, even though it is still down 23.9% year to date and 24.0% over the past year. This tells you sentiment has started to shift, but long-term holders may still be underwater. That recent surge has been driven largely by improving confidence in the commercial...
NYSE:GD
NYSE:GDAerospace & Defense

General Dynamics (GD) Valuation Check as Shares Cool After Strong Year-to-Date Rally

General Dynamics (GD) has quietly cooled off after a strong run this year, slipping about 3% over the past month even as its year to date gain still sits near 29%. See our latest analysis for General Dynamics. At around $337.49 per share, General Dynamics has eased back from recent highs. That softer 30 day share price return comes after a powerful year to date climb, with longer term total shareholder returns still suggesting momentum is cooling rather than collapsing. If you are reassessing...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Has Micron’s 176% AI Fueled Surge Already Priced In Its Growth Potential?

If you are wondering whether Micron Technology is still a smart buy after its massive run up, or if the easy money has already been made, you are in the right place. The stock has surged 176.1% year to date and 136.2% over the last year. This comes even with a small 1.5% pullback in the past month and a 1.7% gain over the last week, which hints that investor expectations and perceived risk are shifting fast. Recent headlines have zeroed in on Micron as a key beneficiary of demand for high...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Concentrix (CNXC): Assessing Valuation After Webhelp Integration Progress and New AI Governance Certifications

Concentrix (CNXC) just checked two big boxes for investors, advancing its Webhelp integration while locking in top tier AI governance certifications, and together these moves are quietly reshaping how the market views its story. See our latest analysis for Concentrix. Even with the Webhelp integration progressing and fresh AI certifications in hand, Concentrix is still trying to win back trust. Its 11.9% 1 month share price return contrasts sharply with a much weaker 3 year total shareholder...
NasdaqGS:IRDM
NasdaqGS:IRDMTelecom

Can Iridium (IRDM) Turn Hyundai’s IoT Deal and New Board Hire Into Durable Service-Margin Strength?

In early December 2025, Iridium Communications declared a US$0.15 per share cash dividend payable on December 31 and added experienced telecom and cloud executive Louis Alterman to its expanded 12-member board, while HD Hyundai Construction Equipment selected Iridium to power global satellite connectivity for its Hi MATE remote fleet management system. Together, the Hyundai partnership and governance changes highlight Iridium’s push deeper into industrial IoT and enterprise mobility,...
NYSE:WES
NYSE:WESOil and Gas

Has Western Midstream Run Its Course After A 314% Surge And Capital Allocation Shift?

Wondering if Western Midstream Partners is still good value after such a big multi year run? This article will walk through whether the current price makes sense or if the market is getting ahead of itself. After climbing an impressive 313.7% over 5 years and 97.3% over 3 years, the units have cooled lately, with a 1 year gain of 8.8%, a modest 0.4% return year to date, a 1.3% rise over 30 days, and a slight 1.5% dip in the last week. Recent headlines have focused on Western Midstream...
NYSE:NX
NYSE:NXBuilding

Quanex Building Products (NX) Valuation After Profitable Q4, Full-Year Loss and Cautious 2026 Outlook

Q4 earnings turn profitable as full year stays in the red Quanex Building Products (NX) just posted a profitable fourth quarter while still closing fiscal 2025 with a sizable net loss and cautious, flat guidance for 2026, a mix that has investors reassessing the stock. See our latest analysis for Quanex Building Products. The upbeat fourth quarter has sparked a sharp near term reset in sentiment, with a 1 month share price return of 25.34 percent and a 7 day gain of 19.28 percent. However,...
NYSE:ET
NYSE:ETOil and Gas

Is Energy Transfer (ET) Undervalued After This Year’s 16% Slide?

Energy Transfer (ET) has quietly slid this year, with the unit price down about 16% year to date even as the partnership continues to post growing revenue and double digit net income gains. See our latest analysis for Energy Transfer. That slide reflects fading near term momentum, with a year to date share price return of negative 15.98 percent, even though the five year total shareholder return sits at a hefty 263.47 percent. If Energy Transfer’s pullback has you thinking about where else...
NYSE:CNM
NYSE:CNMTrade Distributors

Assessing Core & Main (CNM) Valuation After Steady Q3 Results and Renewed Growth, M&A and Buyback Push

Core & Main (CNM) just checked several important boxes for investors, delivering steady third quarter growth, reaffirming its full year outlook, and leaning into acquisitions, buybacks, and expansion in Canada. See our latest analysis for Core & Main. That mix of steady execution and bolder moves on M&A and buybacks has helped CNM rebound, with a 7 day share price return of 11.67% and a powerful three year total shareholder return of 182.14%, suggesting momentum is rebuilding after earlier...
NYSE:PUMP
NYSE:PUMPEnergy Services

Why ProPetro (PUMP) Is Down 6.1% After PROPWR’s New Permian Microgrid Deal And Capex Hike

ProPetro Holding Corp. recently announced that its PROPWR division signed a contract with a Coterra Energy subsidiary to develop and install distributed microgrids across the New Mexico Permian Basin, lifting committed capacity to over 220 megawatts and prompting higher 2026 capital expenditure guidance of US$250 million to US$275 million. This move accelerates PROPWR’s push toward a one-gigawatt portfolio by 2030 and underscores a shift toward longer-term, power-focused contracts that could...
NYSE:ELV
NYSE:ELVHealthcare

Assessing Elevance Health (ELV) Valuation as Its Virtual Assistant Scales to 22 Million Members

Elevance Health (ELV) is leaning into digital tools with its expanded Virtual Assistant, now reaching 22 million commercial members and aiming to simplify everything from coverage questions to cost estimates in real time. See our latest analysis for Elevance Health. Those digital moves, alongside Elevance Health's board refresh with Amy Schulman joining as an independent director, come as momentum has quietly improved, with a 90 day share price return of 15.18 percent contrasting with a three...
NYSE:SRE
NYSE:SREIntegrated Utilities

Taking Stock of Sempra (SRE): Assessing Valuation After Recent Share Price Cooling

Valuation backdrop and recent performance Sempra (SRE) has quietly slipped about 4 % over the past month even as its past 3 months return remains positive, creating an interesting setup for investors watching regulated utility names. See our latest analysis for Sempra. At around $88.49, Sempra’s recent 7 day and 30 day share price declines contrast with a modestly positive year to date share price return and solid multi year total shareholder returns. This suggests momentum has cooled, while...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Stock Has Quietly Rallied: Is the Beverage Giant Now Over or Undervalued?

Why Coca-Cola Stock Is Back on Investors Radar Coca-Cola (KO) has quietly outperformed the wider market over the past year, and with the stock up about 5% in the past 3 months, investors are revisiting its long term appeal. See our latest analysis for Coca-Cola. The latest move takes Coca-Cola's share price to $70.52, and that steady upward drift, alongside a roughly 15% one year total shareholder return, suggests resilient momentum as investors lean into its dependable earnings and dividend...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Assessing Arcutis Biotherapeutics After 99% Rally and DCF Signals Further Upside Potential

If you are wondering whether Arcutis Biotherapeutics is still a smart bet after its big run, or if most of the upside is already priced in, you are not alone. That is exactly what we are going to unpack. The stock has pulled back about 7.0% over the last week, but that comes after a sharp 23.8% gain in the past month and a 99.3% rise year to date, with a 128.7% return over the last year that has completely changed how the market looks at this name. Those moves have been fueled by a series of...